ATC Group: A02BA02 Ranitidine

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
H2-receptor antagonists
5
A02BA02
Ranitidine

Active ingredients

Active Ingredient
Description

Ranitidine is a specific rapidly acting histamine H2-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion. Ranitidine has a relatively long duration of action and so a single 150 mg dose effectively suppresses gastric acid secretion for twelve hours.

Medicines in this ATC group

Drug
Countries

Singapore

Hong Kong

Brazil

Australia

South Africa

South Africa

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Singapore

South Africa

United Kingdom

Hong Kong

Singapore

South Africa

Hong Kong Singapore

Brazil

Cyprus Singapore

Lithuania

Brazil

Hong Kong

New Zealand

Hong Kong

Hong Kong

Singapore

Lithuania Poland

Poland

United Kingdom

Hong Kong

Lithuania Poland

Cyprus Hong Kong

Lithuania Poland

Lithuania

Hong Kong

Tunisia

Hong Kong

Hong Kong

Poland

Tunisia

Hong Kong

Hong Kong

Singapore

Hong Kong

Hong Kong

Singapore

Hong Kong

Singapore

Australia Canada Cyprus Hong Kong Lithuania ...

Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK